Synopsis
Synopsis
0
EU WC
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Omacor
2. Omega-3 Ethyl Ester 90
3. P-om3 Adjunct
1. 861006-80-6
2. Omacor
3. Coromega
4. Lotriga
5. Zodin
6. Ethyl (4z,7z,10z,13z,16z,19z)-docosa-4,7,10,13,16,19-hexaenoate Compound With Ethyl (5z,8z,11z,14z,17z)-icosa-5,8,11,14,17-pentaenoate (1:1)
7. Omega-3 Acid Ethyl Esters
8. Omega-3-acid Ethyl Ester
9. Omega-3-acid Ethyl Esters
10. Chembl1200711
11. Tak-085
12. Omega-3-acid Ethyl Esters Type A
13. Icosapent (epa Ethyl Ester)
14. Doconexent (dha Ethyl Ester)
15. K-85
16. 4,7,10,13,16,19-docosahexaenoic Acid, Ethyl Ester, (4z,7z,10z,13z,16z,19z)-, Mixt. With (5z,8z,11z,14z,17z)-ethyl 5,8,11,14,17-eicosapentaenoate
17. Ethyl (4z,7z,10z,13z,16z,19z)-docosa-4,7,10,13,16,19-hexaenoate;ethyl (5z,8z,11z,14z,17z)-icosa-5,8,11,14,17-pentaenoate
| Molecular Weight | 687.0 g/mol |
|---|---|
| Molecular Formula | C46H70O4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 31 |
| Exact Mass | 686.52741071 g/mol |
| Monoisotopic Mass | 686.52741071 g/mol |
| Topological Polar Surface Area | 52.6 Ų |
| Heavy Atom Count | 50 |
| Formal Charge | 0 |
| Complexity | 916 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 11 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 4 | |
|---|---|
| Drug Name | Lovaza |
| Drug Label | LOVAZA, a lipid-regulating agent, is supplied as a liquid-filled gel capsule for oral administration. Each 1-gram capsule of LOVAZA contains at least 900 mg of the ethyl esters of omega-3 fatty acids sourced from fish oils. These are predominantly a... |
| Active Ingredient | Omega-3-acid ethyl esters |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | 1gm contains at least 900mg of the ethyl esters of omega-3 fatty acids |
| Market Status | Prescription |
| Company | Smithkline Beecham |
| 2 of 4 | |
|---|---|
| Drug Name | Omega-3-acid ethyl esters |
| Drug Label | LOVAZA, a lipid-regulating agent, is supplied as a liquid-filled gel capsule for oral administration. Each 1-gram capsule of LOVAZA contains at least 900 mg of the ethyl esters of omega-3 fatty acids sourced from fish oils. These are predominantly a... |
| Active Ingredient | Omega-3-acid ethyl esters |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | 1gm contains at least 900mg of the ethyl esters of omega-3 fatty acids |
| Market Status | Prescription |
| Company | Apotex; Teva Pharms Usa; Par Pharm |
| 3 of 4 | |
|---|---|
| Drug Name | Lovaza |
| Drug Label | LOVAZA, a lipid-regulating agent, is supplied as a liquid-filled gel capsule for oral administration. Each 1-gram capsule of LOVAZA contains at least 900 mg of the ethyl esters of omega-3 fatty acids sourced from fish oils. These are predominantly a... |
| Active Ingredient | Omega-3-acid ethyl esters |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | 1gm contains at least 900mg of the ethyl esters of omega-3 fatty acids |
| Market Status | Prescription |
| Company | Smithkline Beecham |
| 4 of 4 | |
|---|---|
| Drug Name | Omega-3-acid ethyl esters |
| Drug Label | LOVAZA, a lipid-regulating agent, is supplied as a liquid-filled gel capsule for oral administration. Each 1-gram capsule of LOVAZA contains at least 900 mg of the ethyl esters of omega-3 fatty acids sourced from fish oils. These are predominantly a... |
| Active Ingredient | Omega-3-acid ethyl esters |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | 1gm contains at least 900mg of the ethyl esters of omega-3 fatty acids |
| Market Status | Prescription |
| Company | Apotex; Teva Pharms Usa; Par Pharm |
Omega-3-Acid Ethyl Esters capsules, USP are indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (500 mg/dL) hypertriglyceridemia (HTG).
FDA Label
Omega-3-acid ethyl esters reduce triglyceride production, increase fatty acid metabolism, inhibit the release of fatty acids, increase triglyceride clearance, and decrease production of very low density lipoprotein cholesterol(VLDL-C).
Absorption
Omega-3-acid ethyl esters are rapidly hydrolysed to free fatty acids in the intestinal lumen which then become incorporated into phospholipids, cholesterol, and triglycerides so determination of bioavailability by serum concentration is not possible.
Route of Elimination
Includes oxidative catabolism to carbon dioxide and water
Volume of Distribution
82 56L
Clearance
757 mL/h 283mL/h.
Omega-3-acid ethyl esters are hydrolysed to free fatty acids in the intestinal lumen by pancreatic lipase. Once in enterocytes, the free fatty acids are packaged in chylomicrons which are released from cells into the circulation. Fatty acids then enter the liver where they can be incorporated into liver stores, incorporated into lipoprotein phospholipids, or oxidised for energy.
79 hours 47 hours.
Omega-3-acid ethyl esters reduce triglyceride production by the liver but this mechanism is not well understood. Omega-3-acid ethyl esters inhibit acyl-CoA:1,2-diacylglycerol acyltransferase, reducing triglyceride synthesis and increasing paroxysmal beta-oxidation, which increases fatty aside metabolism. Omega-3-acid ethyl esters also inhibit the release of fatty acids by competing for enzymes involved in the synthesis of triglycerides, increase triglyceride clearance by increasing the activity of lipoprotein lipase, and decrease production of VLDL-C.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28263
Submission : 2014-12-23
Status : Active
Type : II

GDUFA
DMF Review : Reviewed
Rev. Date : 2020-06-08
Pay. Date : 2020-02-21
DMF Number : 26570
Submission : 2012-10-16
Status : Active
Type : II
Certificate Number : CEP 2024-242 - Rev 00
Issue Date : 2024-09-11
Type : Chemical
Substance Number : 1250
Status : Valid
Registrant Name : Pharmaline Co., Ltd.
Registration Date : 2025-07-02
Registration Number : Su1881-1-ND(2)
Manufacturer Name : KinOmega Biopharm Inc.
Manufacturer Address : No. 161, South Yinghuashan Road, Shifang, Deyang City, Sichuan, China.

GDUFA
DMF Review : Reviewed
Rev. Date : 2021-02-13
Pay. Date : 2021-02-03
DMF Number : 22106
Submission : 2008-10-17
Status : Active
Type : II
Certificate Number : R1-CEP 2010-230 - Rev 01
Issue Date : 2017-08-23
Type : Chemical
Substance Number : 1250
Status : Valid
Registration Number : 302MF10071
Registrant's Address : Cowick Hall, Snaith, Google, East Yorkshire, DN14 9AA, England
Initial Date of Registration : 2020-06-26
Latest Date of Registration :
Registrant Name : Geonil Pharmaceutical Co., Ltd.
Registration Date : 2018-06-11
Registration Number : Su353-1-ND(1)
Manufacturer Name : Croda Europe Limited
Manufacturer Address : Barnfield Road Leek Staffordshire ST13 5QJ

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33665
Submission : 2019-03-25
Status : Active
Type : IV
Certificate Number : R1-CEP 2015-057 - Rev 00
Issue Date : 2020-07-16
Type : Chemical
Substance Number : 1250
Status : Valid
Registrant Name : MFC Co., Ltd.
Registration Date : 2018-06-11
Registration Number : Su353-1-ND(2)
Manufacturer Name : Croda Europe Limited
Manufacturer Address : Barnfield Road Leek Staffordshire ST13 5QJ

GDUFA
DMF Review : Reviewed
Rev. Date : 2016-07-28
Pay. Date : 2016-03-15
DMF Number : 28246
Submission : 2014-05-19
Status : Active
Type : II
Certificate Number : R1-CEP 2014-007 - Rev 00
Issue Date : 2020-05-28
Type : Chemical
Substance Number : 1250
Status : Valid

GDUFA
DMF Review : Reviewed
Rev. Date : 2013-11-13
Pay. Date : 2013-01-22
DMF Number : 23369
Submission : 2010-01-06
Status : Active
Type : II
Certificate Number : CEP 2017-298 - Rev 05
Issue Date : 2025-06-20
Type : Chemical
Substance Number : 1352
Status : Valid
Registration Number : 223MF10051
Registrant's Address : Lilleakerveien 2B, NO-0283 Oslo, Norway P. O. Box 420, NO-1327 Lysaker, Norway
Initial Date of Registration : 2011-04-12
Latest Date of Registration :
Registrant Name : BASF Korea Ltd.
Registration Date : 2012-12-27
Registration Number : Su6246-1-ND
Manufacturer Name : BASF Pharma (Callanish) Ltd
Manufacturer Address : Breasclete, Callanish, Isle of Lewis, HS2 9ED, Scotland

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23510
Submission : 2010-04-21
Status : Active
Type : II
Certificate Number : CEP 2008-132 - Rev 05
Issue Date : 2025-06-23
Type : Chemical
Substance Number : 1250
Status : Valid
Registrant Name : Geonil Pharmaceutical Co., Ltd.
Registration Date : 2005-09-08
Registration Number : 38-1-ND
Manufacturer Name : BASF AS
Manufacturer Address : Framnesveien 41, SANDEFJORD, NO-3222, Norway

GDUFA
DMF Review : Reviewed
Rev. Date : 2014-08-20
Pay. Date : 2013-12-16
DMF Number : 26056
Submission : 2012-08-31
Status : Active
Type : II
Certificate Number : CEP 2008-330 - Rev 05
Issue Date : 2025-06-23
Type : Chemical
Substance Number : 1250
Status : Valid

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29192
Submission : 2015-06-12
Status : Active
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
GDUFA
DMF Review : Complete
Rev. Date : 2013-11-13
Pay. Date : 2013-01-22
DMF Number : 23369
Submission : 2010-01-06
Status : Active
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2014-08-20
Pay. Date : 2013-12-16
DMF Number : 26056
Submission : 2012-08-31
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23510
Submission : 2010-04-21
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14685
Submission : 2000-01-26
Status : Inactive
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2014-04-28
Pay. Date : 2013-11-06
DMF Number : 25342
Submission : 2011-09-07
Status : Active
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2021-02-13
Pay. Date : 2021-02-03
DMF Number : 22106
Submission : 2008-10-17
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26559
Submission : 2012-10-15
Status : Inactive
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2013-10-31
Pay. Date : 2013-10-21
DMF Number : 22285
Submission : 2008-10-17
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22284
Submission : 2008-11-03
Status : Inactive
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : R1-CEP 2014-182 - Rev 00
Status : Valid
Issue Date : 2021-02-09
Type : Chemical
Substance Number : 1250

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Omega-3-acid Ethyl Esters 90, With Antioxidant Î...
Certificate Number : R1-CEP 2010-230 - Rev 01
Status : Valid
Issue Date : 2017-08-23
Type : Chemical
Substance Number : 1250

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Omega-3-acid Ethyl Esters 90, RF08200, With Mixe...
Certificate Number : R1-CEP 2015-267 - Rev 00
Status : Valid
Issue Date : 2020-10-26
Type : Chemical
Substance Number : 1250

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Omega-3-acid Ethyl Esters 90, Grade RF07800, Wit...
Certificate Number : R1-CEP 2015-057 - Rev 00
Status : Valid
Issue Date : 2020-07-16
Type : Chemical
Substance Number : 1250

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Omega-3-acid Ethyl Esters 90, With α-tocopherol
Certificate Number : R0-CEP 2012-244 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2013-10-23
Type : Chemical
Substance Number : 1250

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Omega-3-acid Ethyl Esters 90, With 0.03% RRR-alp...
Certificate Number : R1-CEP 2017-120 - Rev 01
Status : Valid
Issue Date : 2023-01-10
Type : Chemical
Substance Number : 1250

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Omega-3-acid Ethyl Esters 90, With RRR-alpha-toc...
Certificate Number : R1-CEP 2014-323 - Rev 02
Status : Valid
Issue Date : 2023-01-09
Type : Chemical
Substance Number : 1250

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Omega-3-acid Ethyl Esters 90, With Mixed Tocophe...
Certificate Number : R1-CEP 2017-130 - Rev 01
Status : Valid
Issue Date : 2023-01-05
Type : Chemical
Substance Number : 1250

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Omega-3-acid Ethyl Esters 90, With Alpha-tocophe...
Certificate Number : R1-CEP 2014-064 - Rev 01
Status : Valid
Issue Date : 2021-12-06
Type : Chemical
Substance Number : 1250

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Omega-3-acid Ethyl Esters 90, With RRR-alpha-toc...
Certificate Number : R0-CEP 2020-332 - Rev 00
Status : Valid
Issue Date : 2022-03-29
Type : Chemical
Substance Number : 1250

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Registration Number : 303MF10032
Registrant's Address : #81, Sanggae-Ro, Nam-Gu, Ulsan, Korea
Initial Date of Registration : 2021-02-16
Latest Date of Registration : 2021-02-16

Registration Number : 223MF10051
Registrant's Address : Lilleakerveien 2B, NO-0283 Oslo, Norway P. O. Box 420, NO-1327 Lysaker, Norway
Initial Date of Registration : 2011-04-12
Latest Date of Registration : 2025-05-08

Omega-3-Fatty Acid Ethyl Esters 90
Registration Number : 302MF10071
Registrant's Address : Cowick Hall, Snaith, Google, East Yorkshire, DN14 9AA, England
Initial Date of Registration : 2020-06-26
Latest Date of Registration : 2020-06-26

Omega-3 fatty acid ethyl esters
Registration Number : 304MF10004
Registrant's Address : Am Kraftwerk 6,66450 Bexbach, Germany
Initial Date of Registration : 2022-01-11
Latest Date of Registration : 2022-01-11

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]About the Company : Axplora, created from the merger of Farmabios, Novasep & PharmaZell, is a leading API manufacturing partner to the world’s leading pharma & biotech companies, delivering top-qual...
About the Company : We create chemistry for a sustainable future. In line with our corporate purpose, around 112,000 employees contribute to the success of our customers in nearly all sectors and alm...

About the Company : Guowei Pharmaceutical was established in 2005 and is headquartered in Chengdu High-tech Zone. Its subsidiaries include Chengdu Guowei Biopharmaceutical Co., Ltd., Sichuan Guowei Ph...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Lipomeg
Dosage Form : Soft Capsule
Dosage Strength : 1000mg
Packaging :
Approval Date : 27-03-2019
Application Number : 28106042717
Regulatory Info : Prescription
Registration Country : Denmark
Delivering quality and niche Active Pharmaceutical Ingredients across the global from our USFDA-approved facility.
Regulatory Info : RX
Registration Country : USA
Brand Name : OMEGA-3-ACID ETHYL ESTERS
Dosage Form : CAPSULE;ORAL
Dosage Strength : 1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
Packaging :
Approval Date : 2021-11-15
Application Number : 215458
Regulatory Info : RX
Registration Country : USA
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Brand Name : OMEGA-3-ACID ETHYL ESTERS
Dosage Form : CAPSULE;ORAL
Dosage Strength : 1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
Packaging :
Approval Date : 2015-11-27
Application Number : 204940
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Brand Name : OMEGA-3-ACID ETHYL ESTERS
Dosage Form : CAPSULE;ORAL
Dosage Strength : 1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
Packaging :
Approval Date : 2014-09-30
Application Number : 90973
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Brand Name : OMEGA-3-ACID ETHYL ESTERS
Dosage Form : CAPSULE;ORAL
Dosage Strength : 1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
Packaging :
Approval Date : 2019-08-07
Application Number : 206455
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Brand Name : OMEGA-3-ACID ETHYL ESTERS
Dosage Form : CAPSULE;ORAL
Dosage Strength : 1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
Packaging :
Approval Date : 2014-04-07
Application Number : 91028
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : DISCN
Registration Country : USA
OMEGA-3-ACID ETHYL ESTERS TYPE A
Brand Name : OMTRYG
Dosage Form : CAPSULE;ORAL
Dosage Strength : 1.2GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
Packaging :
Approval Date : 2014-04-23
Application Number : 204977
Regulatory Info : DISCN
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Brand Name : LOVAZA
Dosage Form : CAPSULE;ORAL
Dosage Strength : 1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
Packaging :
Approval Date : 2004-11-10
Application Number : 21654
Regulatory Info : RX
Registration Country : USA

Regulatory Info :
Registration Country : USA
Brand Name : OMACOR
Dosage Form : CAPSULE; ORAL
Dosage Strength : 1G
Packaging :
Approval Date :
Application Number : 21853
Regulatory Info :
Registration Country : USA

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : OMEGA-3-ACID ETHYL ESTERS
Dosage Form : CAPSULE;ORAL
Dosage Strength : 1GM CONTAINS AT LEAST 900MG OF THE ETHYL ESTERS OF OMEGA-3 FATTY ACIDS
Packaging :
Approval Date : 2014-06-24
Application Number : 91018
Regulatory Info : DISCN
Registration Country : USA

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Dosage Form : Tablet
Grade : Oral
Dosage Form : Cream / Lotion / Ointment
Grade : Topical, Parenteral
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Tablet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Enteric Coatings
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Tablet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Immediate Release
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Tablet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Enteric Coatings
Dosage Form : Tablet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Immediate Release
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Cellulose
Dosage Form : Tablet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Immediate Release
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Tablet
Grade : Not Available
Application : Coating Systems & Additives
Excipient Details : Immediate Release
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Tablet
Grade : Not Available
Brand Name : SheffCoatâ„¢ TF Nutra
Application : Coating Systems & Additives
Excipient Details : Titanium Oxide Free Coatings
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Tablet
Grade : Not Available
Brand Name : SheffCoatâ„¢ TF Plus
Application : Coating Systems & Additives
Excipient Details : Titanium Oxide Free Coatings
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Tablet
Grade : Not Available
Brand Name : SheffCoatâ„¢Enhance
Application : Coating Systems & Additives
Excipient Details : Immediate Release
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Hydroxypropyl Methyl Cellulose
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Global Sales Information
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2019 Revenue in Millions : 292
2018 Revenue in Millions : 292
Growth (%) : 0

Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2020 Revenue in Millions : 299
2019 Revenue in Millions : 298
Growth (%) : 0

Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2021 Revenue in Millions : 268
2020 Revenue in Millions : 287
Growth (%) : 1

Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2022 Revenue in Millions : 163
2021 Revenue in Millions : 268
Growth (%) : -39

Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2023 Revenue in Millions : 23
2022 Revenue in Millions : 61
Growth (%) : -57

Omega-3 Polyunsaturated Fatty Acids
Main Therapeutic Indication : Cardiovascular
Currency : USD
2015 Revenue in Millions : 341
2014 Revenue in Millions : 132
Growth (%) : -61%

Omega-3 Polyunsaturated Fatty Acids
Main Therapeutic Indication : Cardiovascular
Currency : USD
2014 Revenue in Millions : -58.90%
2013 Revenue in Millions :
Growth (%) :

Omega-3 Polyunsaturated Fatty Acids
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2016 Revenue in Millions : 53
2015 Revenue in Millions : 115
Growth (%) : -54

Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2016 Revenue in Millions : 239
2015 Revenue in Millions : 189
Growth (%) : 27

Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2017 Revenue in Millions : 300
2016 Revenue in Millions : 255
Growth (%) : 17

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Reply
14 Jul 2021

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Reply
19 Oct 2020

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
ABOUT THIS PAGE
20
PharmaCompass offers a list of Omega-3-Acid Ethyl Esters 90 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Omega-3-Acid Ethyl Esters 90 manufacturer or Omega-3-Acid Ethyl Esters 90 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Omega-3-Acid Ethyl Esters 90 manufacturer or Omega-3-Acid Ethyl Esters 90 supplier.
PharmaCompass also assists you with knowing the Omega-3-Acid Ethyl Esters 90 API Price utilized in the formulation of products. Omega-3-Acid Ethyl Esters 90 API Price is not always fixed or binding as the Omega-3-Acid Ethyl Esters 90 Price is obtained through a variety of data sources. The Omega-3-Acid Ethyl Esters 90 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Zodin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Zodin, including repackagers and relabelers. The FDA regulates Zodin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Zodin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Zodin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Zodin supplier is an individual or a company that provides Zodin active pharmaceutical ingredient (API) or Zodin finished formulations upon request. The Zodin suppliers may include Zodin API manufacturers, exporters, distributors and traders.
click here to find a list of Zodin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Zodin DMF (Drug Master File) is a document detailing the whole manufacturing process of Zodin active pharmaceutical ingredient (API) in detail. Different forms of Zodin DMFs exist exist since differing nations have different regulations, such as Zodin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Zodin DMF submitted to regulatory agencies in the US is known as a USDMF. Zodin USDMF includes data on Zodin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Zodin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Zodin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Zodin Drug Master File in Japan (Zodin JDMF) empowers Zodin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Zodin JDMF during the approval evaluation for pharmaceutical products. At the time of Zodin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Zodin suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Zodin Drug Master File in Korea (Zodin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Zodin. The MFDS reviews the Zodin KDMF as part of the drug registration process and uses the information provided in the Zodin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Zodin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Zodin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Zodin suppliers with KDMF on PharmaCompass.
A Zodin CEP of the European Pharmacopoeia monograph is often referred to as a Zodin Certificate of Suitability (COS). The purpose of a Zodin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Zodin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Zodin to their clients by showing that a Zodin CEP has been issued for it. The manufacturer submits a Zodin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Zodin CEP holder for the record. Additionally, the data presented in the Zodin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Zodin DMF.
A Zodin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Zodin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Zodin suppliers with CEP (COS) on PharmaCompass.
Zodin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Zodin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Zodin GMP manufacturer or Zodin GMP API supplier for your needs.
A Zodin CoA (Certificate of Analysis) is a formal document that attests to Zodin's compliance with Zodin specifications and serves as a tool for batch-level quality control.
Zodin CoA mostly includes findings from lab analyses of a specific batch. For each Zodin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Zodin may be tested according to a variety of international standards, such as European Pharmacopoeia (Zodin EP), Zodin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Zodin USP).